Skip to main content

Compromising ethics for more profits? Top pharma cos' products 'failing to meet standards'

By Vikas Meshram* 

The news that 53 medicines claiming to relieve ailments such as fever, pain, high blood pressure, diabetes, etc., have failed to meet quality standards during trials is concerning. The inclusion of Paracetamol, a widely used medicine in the country, among these is ironic. It is astonishing that these medicines are being sold openly under the nose of the government. The Central Drug Regulator has released a list of medicines that do not meet quality standards. 
The general public is left wondering how these substandard drugs affect our health. Moreover, has any action been taken against those selling inferior medicines? As of now, no official information has been released in this regard. Undoubtedly, this is shameful and exposes the failure of the system, where the medicines people buy to alleviate physical suffering are substandard. It is highly likely that such inferior medicines could also have negative consequences. Serious research is needed in this regard.
Importantly, the medicine Paracetamol, which is commonly taken by people, also failed in the trials. It is generally believed that this medicine is effective in treating occasional fevers, pains, etc. Including it in the Central Drug Regulator's list of substandard medicines will undoubtedly break people's trust. It is unfortunate that human values have declined to the extent that people do not hesitate to play with the lives of suffering patients for their own benefit.
Although the CDSCO (Central Drugs Standard Control Organization) has tested the quality of 53 medicines, only a list of 48 was eventually released. The reason behind this is that five of the listed medicines were claimed by the manufacturing companies to be fake drugs being sold under their brand names. The unethical practices in the pharmaceutical industry are increasing the crisis in people's lives. While the Drug Standard Control Organization has banned these medicines, today, these medicines are not saving millions of lives; instead, human greed is taking them.
Many branded companies' medicines have also been included in the list of substandard and defective drugs. Despite strict processes in place to ensure the quality of medicines, cases of substandard medicines continue to surface. Even well-known pharmaceutical companies' products are failing to meet the standards, leading one to believe that these companies have begun compromising ethics and humanity for more profits at lower costs. In addition to the issue of inferior drugs, many fake medicines are also being sold. 
These include medicines for BP, diabetes, acid reflux, and certain vitamins. Furthermore, among the medicines that have failed CDSCO's quality standards are Paracetamol (a fever reducer), Diclofenac (a painkiller), and Fluconazole (an antifungal medicine), produced by some of the country's largest pharmaceutical companies, which have also been declared harmful to health.
The release of a list of substandard medicines has raised concerns about the safety of patients' health. Patients take medicine with the hope of recovery. Today, these medicines are not saving millions of lives; human greed is killing them. The inclusion of many branded companies' medicines among substandard and defective drugs is alarming. Despite strict processes to ensure the quality of medicines, these cases of non-compliance with standards keep surfacing. The process includes testing raw materials and inspecting the production process. Even then, if well-known pharmaceutical companies' products fail to meet the standards, it shows that they have begun to sacrifice ethics and humanity for more profits at lower costs.
This is not the first time medicines have failed to meet quality standards. The common public remains with the question: if these medicines do not meet the standards, what are their negative consequences? How much will these substandard medicines affect our health? Also, has any action been taken against those selling inferior medicines? Undoubtedly, this is shameful and highlights the failure of the system, where people buy medicines to reduce physical suffering, only to find them substandard. It is highly likely that such inferior medicines could have negative consequences, and serious research is needed in this regard. The ongoing sale of these medicines poses a threat to people's health.
Meanwhile, the DSCO (Drugs Standards Control Organization) has granted exemptions for some medicines imported from select countries like the USA, Australia, Japan, Canada, and the European Union from routine sample testing. Yet, defects are being found in medicines from companies entering the Indian market. This will negatively affect our image. Any negligence in drug testing is inexcusable, as this malpractice in the pharmaceutical business could become a threat to people's lives. 
The reality is that state governments are also delaying action against pharmaceutical companies run by the powerful and wealthy class, and it is the common people who are paying the price. It is unfortunate that human values have declined to such an extent that people do not hesitate to play with the lives of suffering patients for their own benefit.
Despite strict processes in place to ensure the quality of medicines, cases of substandard medicines continue to surface
This August, the central government banned the sale of 156 fixed-dose combination (FDC) medicines. In fact, these medicines were generally used in the form of cold and fever relief, pain relievers, multivitamins, and antibiotics. The production, distribution, and use of these medicines were banned because they were found to be harmful to patients. 
The government took this decision based on the recommendations of the Drug Technical Advisory Board, but medical quality remains questionable. In fact, the combination of several medicines into one pill is known as fixed-dose combination drugs (FDCs). However, the lack of standards in life-saving medicines used for common ailments is playing with patients' lives.
The culprits selling inferior medicines must be severely punished. Such individuals are only interested in personal enrichment through wealth. Now, it seems that the times have become so absurd that anyone who gets the opportunity is involved in looting. The extent of this is evident when reports emerge of counterfeit injections being made instead of life-saving injections. 
We have become so greedy and inhumane that we have lost all sense of sensitivity, which is why we sell our dignity and mix Paracetamol into injections to sell them. What will all this wealth be worth? Pharmaceutical companies are jeopardizing people's health by compromising on the quality of medicines. Firstly, there are no effective treatments for many diseases, and secondly, the essential medicines used for these diseases are unverified and defective. The government has failed to control this situation.
Millions of people across the country are looking to the administration for a way out. It seems that the government's control over the system is weakening. Where will the common man go? The country that once gave the world a message of nobility, morality, and humanity now stands on the verge of moral collapse. Today, the country is so hollow and frail in terms of values and sensitivity. 
Materialistic and selfish values have taken root so deeply that eradicating them will not be easy. The entire conduct of man has become corrupt. Immorality has infiltrated all small and large businesses. In such circumstances, governments will have to formulate long-term policies, considering the broader implications. The regulatory departments must be held accountable, and those guilty of selling substandard medicines must be punished.
---
*Social activist 

Comments

TRENDING

When democracy becomes a performance: The Tibetan exile experience

By Tseten Lhundup*  I was born in Bylakuppe, one of the largest Tibetan settlements in southern India. From childhood, I grew up in simple barracks, along muddy roads, and in fields with limited resources. Over the years, I have watched our democratic system slowly erode. Observing the recent budget session of the 17th Tibetan Parliament-in-Exile, these “democratic procedures” appear grand and orderly on the surface, yet in reality they amount to little more than empty formalities. The parliamentarians seem largely disconnected from the everyday struggles faced by ordinary exiled Tibetans like us.

Study links sanctions to 500,000 deaths annually leading to rise in global backlash

By Bharat Dogra  International opinion is increasingly turning against the expanding burden of sanctions imposed on a growing number of countries. These measures are contributing to humanitarian crises, intensifying domestic discord, and heightening international tensions, thereby increasing the risks of conflicts and wars. 

Dhurandhar: The Revenge — Blurring the line between fiction and political narrative

By Mohd. Ziyaullah Khan*  "Dhurandhar: The Revenge" does not wait to be remembered; it arrives almost on the heels of its predecessor, released on March 19, 2026, just months after the first film’s December 2025 debut. The speed of its arrival feels less like creative urgency and more like calculated timing—cinema responding not to storytelling rhythm but to the emotional climate of its audience. Director Aditya Dhar, along with actor Yami Gautam, appears acutely aware of this moment and how to harness it.

BJP accounts for 99% of political donations in Gujarat: Corporate giants dominate

By Jag Jivan   An analysis of the official data on donations received by national parties from Gujarat during the Financial Year 2024-25 reveals a staggering concentration of funding, with the Bharatiya Janata Party (BJP) accounting for nearly the entirety of the contributions. The data, compiled in a document titled "National Parties donations received from Gujarat during FY-2024-25," lists thousands of transactions, painting a detailed picture of the financial backing for political parties from one of India’s most industrially significant states.

Alarming decline in India's repair culture threatens circular economy goals: Study

By Jag Jivan  A comprehensive new study by environmental research and advocacy organisation Toxics Link has painted a worrying picture of India's fading repair culture, warning that the trend towards replacement over repair is accelerating the country's already critical e-waste crisis.

Beyond the island: Top mythologist reorients the geography of the Ramayana

By Jag Jivan   In a compelling new analysis that challenges conventional geographical assumptions about the ancient epic, writer and mythologist Devdutt Pattanaik has traced the roots of the Ramayana to the forests and river systems of Central and Eastern India, rather than the peninsular south or the modern island nation of Sri Lanka.

Captains extraordinaire: Ranking cricket’s most influential skippers

By Harsh Thakor*  Ranking the greatest cricket captains is a subjective exercise, often sparking passionate debate among fans. The following list is not merely a tally of wins and losses; it is an assessment of leadership’s deeper impact. My criteria fuse a captain’s playing record with their tactical skill, placing the highest consideration on their ability to reshape a team’s fortunes and inspire those around them. A captain who inherited a dominant empire is judged differently from one who resurrected a nation’s cricket from the doldrums. With that in mind, here is my perspective on the finest leaders the game has ever seen.

Swami Vivekananda's views on caste and sexuality were 'painfully' regressive

By Bhaskar Sur* Swami Vivekananda now belongs more to the modern Hindu mythology than reality. It makes a daunting job to discover the real human being who knew unemployment, humiliation of losing a teaching job for 'incompetence', longed in vain for the bliss of a happy conjugal life only to suffer the consequent frustration.

‘No merit’ in Chakraborty’s claims: Personal ethics talk sans details raises questions

By Jag Jivan  A recent opinion piece published in The Quint by Subhash Chandra Garg has raised questions over the circumstances surrounding the resignation of Atanu Chakraborty from HDFC Bank , with Garg stating that the exit “raises doubts about his own ‘ethics’.” Garg, currently Chief Policy Advisor at Subhanjali and former Secretary of the Department of Economic Affairs, Government of India, writes that the Reserve Bank of India ( RBI ) appears to find no substance in Chakraborty’s claims, noting, “It is clear the RBI sees no merit in Atanu Chakraborty’s wild and vague assertions.”